285 related articles for article (PubMed ID: 11074371)
1. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
2. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
[TBL] [Abstract][Full Text] [Related]
5. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
Shin D; Feltri ML; Wrabetz L
J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
[TBL] [Abstract][Full Text] [Related]
6. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
[TBL] [Abstract][Full Text] [Related]
7. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
9. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
[TBL] [Abstract][Full Text] [Related]
10. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
11. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
13. Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
Weinstock NI; Shin D; Dhimal N; Hong X; Irons EE; Silvestri NJ; Reed CB; Nguyen D; Sampson O; Cheng YC; Lau JTY; Bongarzone ER; Kofler J; Escolar ML; Gelb MH; Wrabetz L; Feltri ML
Neuron; 2020 Jul; 107(1):65-81.e9. PubMed ID: 32375064
[TBL] [Abstract][Full Text] [Related]
14. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.
Feltri ML; Weinstock NI; Favret J; Dhimal N; Wrabetz L; Shin D
Glia; 2021 Oct; 69(10):2309-2331. PubMed ID: 33851745
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.
Rafi MA; Fugaro J; Amini S; Luzi P; de Gala G; Victoria T; Dubell C; Shahinfar M; Wenger DA
Biochem Mol Med; 1996 Aug; 58(2):142-50. PubMed ID: 8812733
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
19. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers.
Victoria T; Rafi MA; Wenger DA
Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004
[TBL] [Abstract][Full Text] [Related]
20. Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.
Kondo Y; Duncan ID
J Neurosci Res; 2016 Nov; 94(11):1195-202. PubMed ID: 27557886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
